Xiaobing Chen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 11
- RNA modifications and cancer 6
- RNA Interference and Gene Delivery 5
-
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 10
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Saiqi Wang (11 shared papers)Minghua Hu (5 shared papers)Xinguang Cao (4 shared papers)Beibei Chen (15 shared papers)Hong‐Min Liu (3 shared papers)Hongping Xia (5 shared papers)Weifeng Xu (9 shared papers)Liangyu Bie (4 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Journal of Clinical Oncology (4 papers)Digestive Diseases and Sciences (3 papers)Frontiers in Pharmacology (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiaobing Chen
64 papers receiving 1.5k citations
Xiaobing Chen's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 643
- Molecular Biology 991
- Oncology 330
- Immunology 131
- Pathology and Forensic Medicine 85
Countries citing papers authored by Xiaobing Chen
This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).
Fields of papers citing papers by Xiaobing Chen
This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 116 | |
| 2 | 2018 | 111 | |
| 3 | Application and synthesis of thiazole ring in clinically approved drugs Hit paper breakdown → | 2023 | 109 |
| 4 | 2009 | 70 | |
| 5 | 2012 | 70 | |
| 6 | 2012 | 68 | |
| 7 | 2016 | 59 | |
| 8 | 2015 | 54 | |
| 9 | 2016 | 50 | |
| 10 | 2020 | 41 | |
| 11 | 2010 | 39 | |
| 12 | 2016 | 38 | |
| 13 | 2019 | 38 | |
| 14 | 2020 | 33 | |
| 15 | 2017 | 31 | |
| 16 | 2017 | 30 | |
| 17 | 2021 | 29 | |
| 18 | 2013 | 28 | |
| 19 | 2018 | 27 | |
| 20 | 2019 | 26 |
About Xiaobing Chen
Xiaobing Chen is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (11 papers), Cancer-related molecular mechanisms research (10 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (6 papers), RNA Interference and Gene Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (643 citations), Molecular Biology (991 citations), Oncology (330 citations), Immunology (131 citations) and Pathology and Forensic Medicine (85 citations). Xiaobing Chen has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Saiqi Wang, Minghua Hu, Xinguang Cao, Beibei Chen, Hong‐Min Liu, Hongping Xia, Weifeng Xu, Liangyu Bie, Honglin Liu and Qingjiang Chen. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Digestive Diseases and Sciences, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.